BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Press Releases

  BioVersys Announces First Patient First Visit in HABP/VABP Pivotal Phase 3 RIV-TARGET Trial of BV100

  April 16, 2026

   · 

  9 min read
• Press Releases

  Covalon Technologies Reports Significant Milestones Spanning Vascular Access, Infection Prevention, and Wound Care

  April 16, 2026

   · 

  6 min read
• Press Releases

  Global First | NMPA Accepts IND Application for Mabwell’s Innovative LILRB4/CD3 TCE Bispecific Antibody 6MW5311

  April 16, 2026

   · 

  6 min read
• Press Releases

  Mabwell Announces Acceptance of Supplemental Biologics License Application by NMPA for MAIWEIJIAN (Denosumab)

  April 16, 2026

   · 

  5 min read
• Press Releases

  IQVIA to Announce First-Quarter 2026 Results on May 5, 2026

  April 16, 2026

   · 

  2 min read
• Press Releases

  Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 15, 2026

  April 16, 2026

   · 

  2 min read
• Press Releases

  Acadia Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 6, 2026

  April 16, 2026

   · 

  1 min read
• Press Releases

  Johnson & Johnson to Participate in the Bank of America 2026 Healthcare Conference

  April 16, 2026

   · 

  1 min read
• Press Releases

  Nkarta Announces FDA Agreement on Outpatient Dosing of NKX019 in Autoimmune Disease, Expanding Access to Community Rheumatology Centers

  April 16, 2026

   · 

  6 min read
• Press Releases

  QuidelOrtho Announces Preliminary Revenue for the First Quarter 2026 and Provides Update on Full-Year 2026 Guidance

  April 16, 2026

   · 

  7 min read